Skip to main content
Quest Diagnostics

Seroprevalence of SARS-CoV-2 IgG Spike and Nucleocapsid Antibodies in Northeast Population: 2023-2024

ADLM 2025

Association for Diagnostics and Laboratory medicine

Chicago, IL, July 27-31 , 2025

Poster presentation: Seroprevalence of SARS-CoV-2 IgG Spike and Nucleocapsid Antibodies in Northeast Population: 2023-2024

Authors: Pratt G, Rao LV

Medical Specialty: Infectious disease, Immunology, Laboratory medicine, COVID-19

Related content

Publication
Prevalence and Co-Detection Rates of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus: A Retrospective Analysis
Publication
Anti-Nucleocapsid SARS-CoV-2 Antibody Seroprevalence in Previously Infected Persons With Immunocompromising Conditions-United States, 2020–2022
Publication
Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions
Publication
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
Publication
Impact of the COVID-19 Pandemic on Blood Lead Testing in Children in the United States
Publication
Nucleocapsid and Spike Protein-Based Anti-SARS-CoV-2 Assay Performance in the Minority and Rural Coronavirus Insights Study: Characteristics of Socioeconomically Disadvantaged Populations with Health Disparities
Publication
Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.